D-Cubed Full report

Publication: D-Cubed Full report 2025

D-Cubed Pharma brings together the complete three-part series authored by Peter Keeling, Founder and Board Chair at Diaceutics PLC.

Drawing on more than a decade of biomarker-driven launches and extensive real-world evidence, the series explores how combining Diagnostics, Data, and Digital is redefining launch performance, expanding patient reach, and establishing a new commercial standard for pharma in 2026 and beyond.

Author(s): Founder and Board Chair at Diaceutics PLC.

Year: 2025

Dcubed report series

DOWNLOAD THE FULL REPORT

Share: